Sarah Bin Abdulqader1, Ziyad Al-Ajlan1, Abdulrahman Albakr1, Wisam Issawi2, Mohammed Al-Bar2, Pablo F Recinos3,4, Saad Alsaleh5, Abdulrazag Ajlan6,7. 1. Department of Neurosurgery, King Saud University, Riyadh, Saudi Arabia. 2. Department of Neurosurgery, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia. 3. Department of Neurosurgery, Cleveland Clinic Foundation, 9500 Euclid Avenue/CA-5, Cleveland, OH, 44195, USA. 4. Minimally Invasive Cranial Base and Pituitary Surgery Program, Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic Foundation, 9500 Euclid Avenue/CA-5, Cleveland, OH, 44195, USA. 5. Department of Otolaryngology-Head and Neck Surgery, King Saud University, Riyadh, Saudi Arabia. 6. Department of Neurosurgery, King Saud University, Riyadh, Saudi Arabia. DR_AJLAN79@hotmail.com. 7. Department of Neurosurgery, Stanford University School of Medicine, 300 Pasteur Drive, Palo Alto, Stanford, CA, 94305, USA. DR_AJLAN79@hotmail.com.
Abstract
PURPOSE: Optic pathway gliomas (OPGs) are low-grade neoplasms that primarily affect children. The management of OPGs remains controversial. Reports on the use of the endoscopic endonasal approach (EEA) in OPGs are extremely limited, and no such reports exist on its utility for pediatric OPGs. Here, we report our results and experience with OPGs treated with the EEA. METHODS: We retrospectively reviewed the medical records of OPG patients who were treated surgically via the EEA at our institutions from 2015 to 2017. Data on the demographics, clinical presentation, surgical complications, clinical outcomes, radiological imaging, and visual outcomes were recorded for each patient. RESULTS: Four cases were identified, with visual disturbances being the predominant complaint. The mean patient age was 15.5 years. Three cases showed normal preoperative hormonal profiles, but one patient had hypothyroidism. All tumors identified in this study were World Health Organization grade I pilocytic astrocytomas. Surgical complications included hypopituitarism in two patients, meningitis in two patients, cerebrospinal fluid leak in one patient, and transient diabetes insipidus in one patient. No patient experienced worsening neurological or visual symptoms postoperatively. CONCLUSIONS: Although our data are preliminary, the EEA provides a direct corridor to OPG with acceptable results in terms of tumor resection and visual outcomes. Hypothalamic-pituitary axis dysfunction remains a limitation of any treatment modality for OPGs and should be considered whenever possible. Definitive conclusions are pending as the learning curve of this approach is steep. Further work is needed to understand patient selection for such an approach.
PURPOSE: Optic pathway gliomas (OPGs) are low-grade neoplasms that primarily affect children. The management of OPGs remains controversial. Reports on the use of the endoscopic endonasal approach (EEA) in OPGs are extremely limited, and no such reports exist on its utility for pediatric OPGs. Here, we report our results and experience with OPGs treated with the EEA. METHODS: We retrospectively reviewed the medical records of OPGpatients who were treated surgically via the EEA at our institutions from 2015 to 2017. Data on the demographics, clinical presentation, surgical complications, clinical outcomes, radiological imaging, and visual outcomes were recorded for each patient. RESULTS: Four cases were identified, with visual disturbances being the predominant complaint. The mean patient age was 15.5 years. Three cases showed normal preoperative hormonal profiles, but one patient had hypothyroidism. All tumors identified in this study were World Health Organization grade I pilocytic astrocytomas. Surgical complications included hypopituitarism in two patients, meningitis in two patients, cerebrospinal fluid leak in one patient, and transient diabetes insipidus in one patient. No patient experienced worsening neurological or visual symptoms postoperatively. CONCLUSIONS: Although our data are preliminary, the EEA provides a direct corridor to OPG with acceptable results in terms of tumor resection and visual outcomes. Hypothalamic-pituitary axis dysfunction remains a limitation of any treatment modality for OPGs and should be considered whenever possible. Definitive conclusions are pending as the learning curve of this approach is steep. Further work is needed to understand patient selection for such an approach.
Authors: Gary Nicolin; Patricia Parkin; Donald Mabbott; Darren Hargrave; Ute Bartels; Uri Tabori; James Rutka; J Raymond Buncic; Eric Bouffet Journal: Pediatr Blood Cancer Date: 2009-12-15 Impact factor: 3.167
Authors: Jia Xu Lim; Enrica E K Tan; Lee Ping Ng; Wan Tew Seow; Kenneth T E Chang; Ru Xin Wong; Wen Shen Looi; David C Y Low; Sharon Y Y Low Journal: Front Surg Date: 2022-05-02
Authors: Ciaran Scott Hill; Mehdi Khan; Kim Phipps; Katherine Green; Darren Hargrave; Kristian Aquilina Journal: Childs Nerv Syst Date: 2021-02-03 Impact factor: 1.475
Authors: Zhuo-Ya Zhou; Xiao-Shu Wang; Yang Gong; Ode La Ali Musyafar; Jiao-Jiao Yu; Gang Huo; Jia-Min Mou; Gang Yang Journal: BMC Surg Date: 2021-02-25 Impact factor: 2.102